Ceftazidime reduces cellular Skp2 to promote type-I interferon activity

This study reveals a new role of Skp2 in regulating IFN-I signalling and IFN-I antiviral activity and reports the antibiotic ceftazidime as a potential repressor of Skp2.PMID:37641430 | DOI:10.1111/imm.13687

Source: Immunology - August 29, 2023 Category: Allergy & Immunology Authors: Caixia Qiao Fan Huang Jiuyi He Qiuyu Wu Zhijin Zheng Tingting Zhang Ying Miao Yukang Yuan Xiangjie Chen Qian Du Yang Xu Depei Wu Zhengyuan Yu Hui Zheng Source Type: research